Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors.

Preuß M, Renner C, Krupp W, Christiansen H, Fischer L, Merkenschlager A, Kieß W, Müller W, Manzo N, Meixensberger J, Nestler U.

Childs Nerv Syst. 2013 Aug;29(8):1263-7. doi: 10.1007/s00381-013-2159-8.

PMID:
23708867
2.

5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature.

Barbagallo GM, Certo F, Heiss K, Albanese V.

Br J Neurosurg. 2014 Dec;28(6):750-4. doi: 10.3109/02688697.2014.913779. Review.

PMID:
24799277
3.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children--a technical report.

Beez T, Sarikaya-Seiwert S, Steiger HJ, Hänggi D.

Acta Neurochir (Wien). 2014 Mar;156(3):597-604. doi: 10.1007/s00701-014-1997-9.

PMID:
24449149
4.

Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas.

Sanai N, Snyder LA, Honea NJ, Coons SW, Eschbacher JM, Smith KA, Spetzler RF.

J Neurosurg. 2011 Oct;115(4):740-8. doi: 10.3171/2011.6.JNS11252.

PMID:
21761971
5.

Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.

Tykocki T, Michalik R, Bonicki W, Nauman P.

Neurol Neurochir Pol. 2012 Jan-Feb;46(1):47-51.

PMID:
22426762
6.

Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.

Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M.

World Neurosurg. 2011 Jul-Aug;76(1-2):120-7. doi: 10.1016/j.wneu.2011.02.005.

PMID:
21839963
7.

Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance.

Utsuki S, Oka H, Sato S, Shimizu S, Suzuki S, Tanizaki Y, Kondo K, Miyajima Y, Fujii K.

Neurol Med Chir (Tokyo). 2007 May;47(5):210-3; discussion 213-4.

8.

5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.

Kamp MA, Felsberg J, Sadat H, Kuzibaev J, Steiger HJ, Rapp M, Reifenberger G, Dibué M, Sabel M.

Acta Neurochir (Wien). 2015 Feb;157(2):207-13; discussion 213-4. doi: 10.1007/s00701-014-2313-4.

PMID:
25547719
9.

Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study.

Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M; 5-ALA Recurrent Glioma Study Group..

Neurosurgery. 2009 Dec;65(6):1070-6; discussion 1076-7. doi: 10.1227/01.NEU.0000360128.03597.C7.

PMID:
19934966
10.

Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, Mert A, Di Ieva A, Tomanek B, Prayer D, Marosi C, Hainfellner JA, Knosp E, Wolfsberger S.

Neurosurg Rev. 2012 Jul;35(3):381-91; discussion 391. doi: 10.1007/s10143-012-0374-5.

PMID:
22407140
11.

5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.

Stummer W, Tonn JC, Goetz C, Ullrich W, Stepp H, Bink A, Pietsch T, Pichlmeier U.

Neurosurgery. 2014 Mar;74(3):310-9; discussion 319-20. doi: 10.1227/NEU.0000000000000267.

12.

Improving the extent of malignant glioma resection by dual intraoperative visualization approach.

Eyüpoglu IY, Hore N, Savaskan NE, Grummich P, Roessler K, Buchfelder M, Ganslandt O.

PLoS One. 2012;7(9):e44885. doi: 10.1371/journal.pone.0044885.

13.
14.

Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.

Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A.

Neurosurgery. 2012 Nov;71(5):927-35; discussion 935-6. doi: 10.1227/NEU.0b013e31826d1e6b.

PMID:
22895402
15.

Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.

Rapp M, Kamp M, Steiger HJ, Sabel M.

World Neurosurg. 2014 Jul-Aug;82(1-2):e277-9. doi: 10.1016/j.wneu.2013.07.002.

PMID:
23871813
16.

5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.

Schucht P, Knittel S, Slotboom J, Seidel K, Murek M, Jilch A, Raabe A, Beck J.

Acta Neurochir (Wien). 2014 Feb;156(2):305-12; discussion 312. doi: 10.1007/s00701-013-1906-7.

PMID:
24449075
17.

Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.

Stummer W, Tonn JC, Mehdorn HM, Nestler U, Franz K, Goetz C, Bink A, Pichlmeier U; ALA-Glioma Study Group..

J Neurosurg. 2011 Mar;114(3):613-23. doi: 10.3171/2010.3.JNS097.

PMID:
20397896
18.

Use of 5-aminolevulinic acid for visualization and resection of a benign pediatric brain tumor.

Ruge JR, Liu J.

J Neurosurg Pediatr. 2009 Nov;4(5):484-6. doi: 10.3171/2009.6.PEDS08428.

PMID:
19877785
19.

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Hadjipanayis CG, Widhalm G, Stummer W.

Neurosurgery. 2015 Nov;77(5):663-73. doi: 10.1227/NEU.0000000000000929. Review.

20.

Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey.

Stummer W, Rodrigues F, Schucht P, Preuss M, Wiewrodt D, Nestler U, Stein M, Artero JM, Platania N, Skjøth-Rasmussen J, Della Puppa A, Caird J, Cortnum S, Eljamel S, Ewald C, González-García L, Martin AJ, Melada A, Peraud A, Brentrup A, Santarius T, Steiner HH; European ALA Pediatric Brain Tumor Study Group..

Acta Neurochir (Wien). 2014 Dec;156(12):2315-24. doi: 10.1007/s00701-014-2234-2.

Items per page

Supplemental Content

Support Center